-
-
-
-
-
-
-
Eli Lilly & Co. (LLY) FY20 EPS Guidance Tops Views, Announces FY21 Financial Guidance
-
-
-
-
-
-
-
Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology
-
-
-
-
-
-
-
Eli Lilly (LLY) Issues FY14 EPS, Revenue Guidance
-
-
-
-
-
-
-
Eli Lilly (LLY) Approves $1.5B Buyback Plan
-
-
-
-
101,926 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

